Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial

Published:2021-10 Issue:10 Volume:32 Page:1276-1285
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hughes B.G.M.^ORCID,Munoz-Couselo E.,Mortier L.,Bratland Å.,Gutzmer R.,Roshdy O.,González Mendoza R.,Schachter J.,Arance A.,Grange F.,Meyer N.,Joshi A.,Billan S.,Zhang P.,Gumuscu B.,Swaby R.F.,Grob J.-J.

Funder

Bayer

Eisai

Takeda Pharmaceutical Company

Merck

Mount Sylvia Diatomite

Merck KGaA

Novartis

Merck Sharp and Dohme

Roche

Les Laboratories Pierre Fabre

AstraZeneca

Bayer Fund

AbbVie

Bristol-Myers Squibb

Pfizer

Amgen

Sanofi

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference23 articles.

1. Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease;Burton;Am J Clin Dermatol,2016

2. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012;Rogers;JAMA Dermatol,2015

3. Management of high-risk squamous cell carcinoma of the skin;Fu;Curr Treat Options Oncol,2016

4. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck;Moore;Laryngoscope,2005

5. Cutaneous squamous-cell carcinoma;Alam;N Engl J Med,2001

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in the Management of Advanced Nonmelanoma Skin Cancer;Surgical Oncology Clinics of North America;2024-10

2. Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients;Cancers;2024-09-10

3. The hidden Australian skin cancer epidemic, high-risk cutaneous squamous cell carcinoma: a narrative review;Pathology;2024-08

4. Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma;Journal of Cutaneous Medicine and Surgery;2024-07-26

5. Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances;Current Oncology Reports;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3